02/18/2026

Registration closes 02/18/2026

Screening of Natural Compounds Against Multi-Drug Resistant (MDR) Bacteria

Harnessing Nature to Combat Antimicrobial Resistance

  • Mode: Virtual / Online
  • Type: Mentor Based
  • Level:
  • Duration: 3 Days ( 1.5 Hours Per Day)
  • Starts: 18 February 2026
  • Time: 08:00 PM IST

About This Course

This three-day workshop (1.5-hour lecture per day) provides a comprehensive understanding of screening natural compounds against multi-drug resistant (MDR) bacteria using experimental and computational approaches. Participants will explore mechanisms of antimicrobial resistance, bioassay-guided screening, molecular docking, and in silico drug discovery tools. Case studies involving pathogens such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa will be discussed. The workshop integrates microbiological techniques with bioinformatics, cheminformatics, and AI tools to accelerate the discovery of novel antimicrobial agents from natural sources.

Aim

To provide theoretical knowledge and practical insights into identifying, screening, and evaluating natural compounds as potential therapeutics against multi-drug resistant bacterial pathogens.

Workshop Objectives

  • Understand mechanisms of antimicrobial resistance and MDR bacteria.
  • Learn sources and extraction methods of bioactive natural compounds.
  • Explore in vitro antimicrobial screening methods (MIC, disk diffusion, broth dilution).
  • Apply computational tools for molecular docking and target prediction.
  • Perform data analysis using Python-based platforms.
  • Understand global AMR action frameworks including initiatives by the World Health Organization.
  • Evaluate translational challenges in natural product drug development.

Workshop Structure

Day 1: Introduction to MDR Bacteria and Natural Compound Libraries

  • MDR Bacteria Overview: Mechanisms of resistance, global impact, and clinical relevance
  • Natural Compounds in Antimicrobial Research: Sources (plants, marine, microbial), chemical diversity, and bioactive classes
  • Compound Libraries and Data Sources: PubChem, ZINC, NPASS, ChEMBL
  • In Silico Screening Concepts: Virtual screening, ligand-based vs structure-based approaches
  • Data Preparation: Compound file formats (SDF, SMILES), bacterial target selection, preprocessing
  • Tools: Python, Pandas, RDKit, Jupyter/Colab

Day 2: Computational Screening and Molecular Docking

  • Molecular Docking Fundamentals: Receptor-ligand interactions, docking algorithms, scoring functions
  • Target Preparation: Choosing MDR bacterial proteins (e.g., β-lactamase, efflux pumps), structure retrieval (PDB), preprocessing
  • Ligand Preparation: Conformer generation, energy minimization, standardization
  • Virtual Screening Workflow: Docking natural compounds against bacterial targets
  • Scoring & Ranking: Binding affinity, interaction profile, hydrogen bonds, hydrophobic contacts
  • Tools: AutoDock Vina, PyRx, RDKit, PyMOL

Day 3: Post-Screening Analysis and Research-Grade Reporting

  • Analysis of Docking Results: Top hits, interaction mapping, and compound-target network visualization
  • ADMET & Drug-Likeness Evaluation: Predicting pharmacokinetics and toxicity for selected hits
  • Hit Prioritization: Multi-criteria scoring based on binding affinity, ADMET, novelty
  • Reproducibility & Reporting: Documenting screening workflow, visualization for publications, and interpretation of results
  • Tools: Python (pandas, matplotlib, seaborn, PyMOL), SwissADME (optional), Jupyter/Colab

Who Should Enrol?

  • Doctoral Scholars & Researchers: PhD candidates seeking to integrate computational workflows into their molecular research.
  • Postdoctoral Fellows: Early-career scientists aiming to enhance their data-driven publication profile.
  • University Faculty: Professors and HODs interested in modern bioinformatics pedagogy and tool mastery.
  • Industry Scientists: R&D professionals from the Biotechnology and Pharmaceutical sectors transitioning to genomic-driven discovery.
  • Postgraduate Students: Final-year PG students looking for specialized research-grade exposure beyond standard curricula.

Important Dates

Registration Ends

02/18/2026
IST 07:00 PM

Workshop Dates

02/18/2026 – 02/20/2026
IST 08:00 PM

Workshop Outcomes

By the end of the workshop, participants will be able to:

  • Explain mechanisms of drug resistance in major bacterial pathogens.
  • Design experimental strategies for screening natural compounds.
  • Interpret antimicrobial susceptibility testing results.
  • Perform basic molecular docking and computational analysis.
  • Analyze screening datasets using statistical and visualization tools.
  • Identify promising lead compounds for further development.

Fee Structure

Student Fee

₹1699 | $65

Ph.D. Scholar / Researcher Fee

₹2699 | $75

Academician / Faculty Fee

₹3699 | $85

Industry Professional Fee

₹4699 | $95

What You’ll Gain

  • Live & recorded sessions
  • e-Certificate upon completion
  • Post-workshop query support
  • Hands-on learning experience

Join Our Hall of Fame!

Take your research to the next level with NanoSchool.

Publication Opportunity

Get published in a prestigious open-access journal.

Centre of Excellence

Become part of an elite research community.

Networking & Learning

Connect with global researchers and mentors.

Global Recognition

Worth ₹20,000 / $1,000 in academic value.

Need Help?

We’re here for you!


(+91) 120-4781-217

★★★★★
Cancer Drug Discovery: Creating Cancer Therapies

Undoubtedly, the professor's expertise was evident, and their ability to cover a vast amount of material within the given timeframe was impressive. However, the pace at which the content was presented made it challenging for some attendees, including myself, to fully grasp and absorb the information.

Mario Rigo
★★★★★
Power BI and Advanced SQL Mastery Integration Workshop, CRISPR-Cas Genome Editing: Workflow, Tools and Techniques

Good! Thank you

Silvia Santopolo
★★★★★
Artificial Intelligence for Cancer Drug Delivery

Informative lectures

G Jyothi
★★★★★
Artificial Intelligence for Cancer Drug Delivery

delt with all the topics associated with the subject matter

RAVIKANT SHEKHAR

View All Feedbacks →

Stay Updated


Join our mailing list for exclusive offers and course announcements

Ai Subscriber